Membrane Transporter/Ion Channel


Membrane Transporters mediate the movement of ions and molecules via binding and moving the substance across the membrane. There are two main actions of transporter: facilitated diffusion (passive transport) and active transport. Membrane transporters which bind the hydrolysis of ATP to the transport of target molecules are referred to as ATPases. For instance, Na+,K+-ATPases or Na+,K+-pumps are responsible for the transport of Na+ out of and K+ into cells.
Ion channels are pore-forming membrane proteins which allow the flow of ions across the membrane. The ion channels can be broadly grouped into six families including calcium channels, chloride channels, potassium channels, sodium channels, gap junction proteins and porins. Not all ion channels are gated, such as certain type of K+ and Cl– channels, transient receptor potential superfamily of cation channels, the ryanodine receptors and the IP3 receptors, but most Na+, K+, Ca2+ and some Cl– channels are all gated by voltage. Ligand-gated channels are regulated in response to ligand binding (e.g. neurotransmitters signaling). These ligand-gated neurotransmitter receptors are known as ionotropic receptors. Various neurotransmitters couple to ionotropic receptors such as glutamate, acetylcholine, glycine, GABA, and serotonin.
-
B8215 JNJ-47965567 -
B8305 Hydroxy Bupropion -
B8327 GSK2330672 -
B8335 Eltanexor (KPT-8602)2 CitationSummary: A second-generation, orally bioavailable XPO1/CRM1 inhibitor -
B5872 RQ-00203078Summary: Selective and orally active TRPM8 antagonist -
B5888 RetigabineSummary: An activator of voltage-gated potassium channel, used as an anticonvulsant agent -
B5894 Rostafuroxin (PST 2238)Summary: Na+/K+ ATPase modulator -
B5895 CARIPORIDETarget: NHESummary: Potent NHE inhibitor -
B5927 GSK1014802(CNV1014802)Summary: Novel sodium channel blocker -
B5930 mavatrepSummary: TRPV1 antagonist

